DSP Mutual Fund cut its stake in Jubilant Ingrevia from 8.08% to 6.37%, selling 54,65,648 shares.
A global integrated provider of life science products and innovative solutions, Jubilant Ingrevia serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers worldwide. The company manufactures customized products designed to be cost-effective and fully compliant with stringent quality standards. Its vertically integrated approach to developing specialized solutions for diverse industry verticals distinguishes it in the competitive basic materials sector.
Standalone AMC after DSP Group acquired full ownership from BlackRock in 2018. Manages over Rs 1.9 lakh crore. Known for equity funds with a clear process-first culture and minimal star manager dependency. CEO Kalpen Parekh is widely respected for transparent investor communication. DSP Small Cap Fund and DSP Midcap Fund are flagship offerings.
